{'fraction_non_alphanumeric': 0.037996545768566495, 'fraction_numerical': 0.018134715025906734, 'mean_word_length': 5.132275132275132, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Liver hydatid disease: long-term results of percutaneous treatment.

PURPOSE
To evaluate the long-term effectiveness of percutaneous treatment of liver hydatid cysts.


MATERIALS AND METHODS
Thirty-one patients (19 female patients and 12 male patients; age range, 8-78 years; mean age, 41 years) with 57 liver hydatid cysts underwent percutaneous treatment. The cysts were treated with hypertonic saline (15% NaCl) and/or absolute alcohol. Sonographic and/or fluoroscopic guidance was used.


RESULTS
Repeated sonography revealed a gradual decrease in cyst size. Volume reduction was 18%-99% (mean, 83%). With the disappearance of the fluid component, pseudotumor appearance occurred. In all treated cases, the cyst wall became irregular and thicker during follow-up. No mortality occurred. No abdominal dissemination was encountered during follow-up. Major complications were infection of the cavity, hypersensitivity reaction, and development of biliary fistula. One cyst recurred 11 months after primary drainage.


CONCLUSION
Long-term results indicate that percutaneous treatment of liver hydatid cysts is an effective and safe method in selected cases.